Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuel Jacky

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|June 13, 2012
Paraneoplastic hyperthyroidismSibylle Kohler, Oliver Tschopp, Emanuel Jacky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumorsAdrian Dubs, Emanuel Jacky, Rolf Stahel, et al.
Oncology|June 26, 2004
False-positive human serum chorionic gonadotropin in a patient with a history of germ cell cancerAndreas Trojan, Helen Joller-Jemelka, Rolf A Stahel, et al.
British Journal of Haematology|January 11, 2005
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studiesGeorgine E de Greef, Wim L J van Putten, Marc Boogaerts, et al.
Cancer Genetics and Cytogenetics|June 15, 2004
Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogeneticsValérie Beyer, Chantal Castagné, Dominique Mühlematter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2005
Prognostic index for adult patients with acute myeloid leukemia in first relapseDimitri A Breems, Wim L J Van Putten, Peter C Huijgens, et al.
Blood|March 17, 2012
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabineThomas Pabst, Edo Vellenga, Wim van Putten, et al.
Blood|January 11, 2007
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?Jan J Cornelissen, Wim L J van Putten, Leo F Verdonck, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|June 13, 2012
Paraneoplastic hyperthyroidismSibylle Kohler, Oliver Tschopp, Emanuel Jacky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumorsAdrian Dubs, Emanuel Jacky, Rolf Stahel, et al.
Oncology|June 26, 2004
False-positive human serum chorionic gonadotropin in a patient with a history of germ cell cancerAndreas Trojan, Helen Joller-Jemelka, Rolf A Stahel, et al.
British Journal of Haematology|January 11, 2005
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studiesGeorgine E de Greef, Wim L J van Putten, Marc Boogaerts, et al.
Cancer Genetics and Cytogenetics|June 15, 2004
Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogeneticsValérie Beyer, Chantal Castagné, Dominique Mühlematter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2005
Prognostic index for adult patients with acute myeloid leukemia in first relapseDimitri A Breems, Wim L J Van Putten, Peter C Huijgens, et al.
Blood|March 17, 2012
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabineThomas Pabst, Edo Vellenga, Wim van Putten, et al.
Blood|January 11, 2007
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?Jan J Cornelissen, Wim L J van Putten, Leo F Verdonck, et al.
Pageof 1